Context Therapeutics Statistics
Total Valuation
CNTX has a market cap or net worth of $150.00 million. The enterprise value is $139.91 million.
Market Cap | 150.00M |
Enterprise Value | 139.91M |
Important Dates
The last earnings date was Wednesday, May 8, 2024, after market close.
Earnings Date | May 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CNTX has 75.00 million shares outstanding.
Shares Outstanding | 75.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 6.86% |
Owned by Institutions (%) | 30.14% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 17.77 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.23, with zero debt.
Current Ratio | 4.23 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -136.00% and return on invested capital (ROIC) is -264.09%.
Return on Equity (ROE) | -136.00% |
Return on Assets (ROA) | -109.50% |
Return on Capital (ROIC) | -264.09% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.26M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +266.17% in the last 52 weeks. The beta is 2.14, so CNTX's price volatility has been higher than the market average.
Beta (1Y) | 2.14 |
52-Week Price Change | +266.17% |
50-Day Moving Average | 1.42 |
200-Day Moving Average | 1.16 |
Relative Strength Index (RSI) | 68.54 |
Average Volume (30 Days) | 556,567 |
Short Selling Information
The latest short interest is 6,533, so 0.01% of the outstanding shares have been sold short.
Short Interest | 6,533 |
Short Previous Month | 40,409 |
Short % of Shares Out | 0.01% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.42 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -22.30M |
Pretax Income | -21.32M |
Net Income | -21.32M |
EBITDA | -21.28M |
EBIT | -21.32M |
Earnings Per Share (EPS) | -$1.33 |
Balance Sheet
The company has $10.09 million in cash and no debt, giving a net cash position of $10.09 million or $0.13 per share.
Cash & Cash Equivalents | 10.09M |
Total Debt | n/a |
Net Cash | 10.09M |
Net Cash Per Share | $0.13 |
Equity / Book Value | 8.44M |
Book Value Per Share | 0.11 |
Working Capital | 8.43M |
Cash Flow
Operating Cash Flow | -19.68M |
Capital Expenditures | n/a |
Free Cash Flow | -19.68M |
FCF Per Share | -$1.23 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CNTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -14.22% |
FCF Yield | -13.12% |
Analyst Forecast
The average price target for CNTX is $6.50, which is 225.00% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.50 |
Price Target Difference | 225.00% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -3.91% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |